The incidence of end-stage renal disease in the diabetic (compared to the non-diabetic) population: A systematic review

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Narres, Maria ^a   Claessen, Heiner ^a   Droste, Sigrid ^b   Kvitkina, Tatjana ^a,b   Koch, Michael ^b,c   Kuss, Oliver ^a,d   Icks, Andrea ^a,b,d  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Center of Nephrology   (Germany)

^d GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; ETHNIC DIFFERENCE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RISK; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ETHNOLOGY; FACTUAL DATABASE; KIDNEY FAILURE, CHRONIC; META ANALYSIS;

DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; RISK FACTORS;

EID: 84958211781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147329     Document Type: Review

References (65)

1. IDF Diabetes Atlas-sixth edition [database on the Internet] 2013. Available from: http://www.idf.org/diabetesatlas. Accessed: 13 July 2015
2. Bell S, Fletcher EH, Brady I, Looker HC, Levin D, Joss N et al. End-stage renal disease and survival in people with diabetes: a national database linkage study. QJM. 2015;108(2):127-34. doi: 10.1093/qjmed/hcu170 PMID: 25140030
3. Lok CE, Oliver MJ, Rothwell DM, Hux JE. The growing volume of diabetes-related dialysis: a population based study. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2004;19(12):3098-103. doi: 10.1093/ndt/gfh540
4. Hendrie GA, Ullah S, Scott JA, Gray J, Berry N, Booth S et al. Past and projected trends of body mass index and weight status in South Australia: 2003 to 2019. Australian and New Zealand journal of public health. 2015. doi: 10.1111/1753-6405.12442
5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. Jama. 2014;311(8):806-14. doi: 10.1001/jama.2014.732 PMID: 24570244
6. Rigobon AV, Birtwhistle R, Khan S, Barber D, Biro S, Morkem R et al. Adult obesity prevalence in primary care users: An exploration using Canadian Primary Care Sentinel Surveillance Network (CPCSSN) data. Canadian journal of public health = Revue canadienne de sante publique. 2015;106(5):e283-9. doi: 10.17269/cjph.106.4508 PMID: 26451989
7. Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L et al. Trends in death rates among U. S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes care. 2012;35(6):1252-7. doi: 10.2337/dc11-1162 PMID: 22619288
8. Gerrits EG, Landman GW, Bilo HJ. Mortality trends in diabetes mellitus. JAMA Intern Med. 2015;175(3):469. doi: 10.1001/jamainternmed.2014.7985 PMID: 25730579
9. Chang YT, Wu JL, Hsu CC, Wang JD, Sung JM. Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998-2009. Diabetes care. 2014;37(1):277-85. doi: 10.2337/dc13-0781 PMID: 23920086
10. Wang AY. Cardiovascular risk in diabetic end-stage renal disease patients. J Diabetes. 2011;3(2):119-31. doi: 10.1111/j.1753-0407.2011.00113.x PMID: 21599866
11. Icks A, Claessen H, Morbach S, Glaeske G, Hoffmann F. Time-dependent impact of diabetes on mortality in patients with stroke: survival up to 5 years in a health insurance population cohort in Germany. Diabetes care. 2012;35(9):1868-75. doi: 10.2337/dc11-2159 PMID: 22688543
12. Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol. 2007;18(7):2125-34. doi: 10.1681/ASN.2006091048 PMID: 17582163
13. Hoffmann F, Haastert B, Koch M, Giani G, Glaeske G, Icks A. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2011;26(5):1634-40. doi: 10.1093/ndt/gfq609
14. Tien KJ, Lin ZZ, Chio CC, Wang JJ, Chu CC, Sun YM et al. Epidemiology and mortality of new-onset diabetes after dialysis: Taiwan national cohort study. Diabetes care. 2013;36(10):3027-32. doi: 10. 2337/dc12-2148 PMID: 23723355
15. Sattar A, Argyropoulos C, Weissfeld L, Younas N, Fried L, Kellum JA et al. All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients. BMC Nephrol. 2012;13:130. doi: 10.1186/1471-2369-13-130 PMID: 23025844
16. Icks A, Haastert B, Gandjour A, Chernyak N, Rathmann W, Giani G et al. Costs of dialysis-a regional population-based analysis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2010;25(5):1647-52. doi: 10. 1093/ndt/gfp672
17. Reutens AT. Epidemiology of diabetic kidney disease. Med Clin North Am. 2013;97(1):1-18. doi: 10. 1016/j.mcna.2012.10.001 PMID: 23290726
18. UNITED STATES RENAL DATA SYSTEM. Atlas of CKD & ESRD. 2013. http://www.usrds.org/atlas.aspx.01.2015.
19. Diabetes care and research in Europe: the Saint Vincent declaration. Diabetic medicine: a journal of the British Diabetic Association. 1990;7(4):360.
20. Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U. S. continues to decline. Diabetes care. 2010;33(1):73-7. doi: 10.2337/dc09-0343 PMID: 20040673
21. Icks A, Haastert B, Genz J, Giani G, Hoffmann F, Trapp R et al. Incidence of renal replacement therapy (RRT) in the diabetic compared with the non-diabetic population in a German region, 2002-08. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2011;26(1):264-9. doi: 10.1093/ndt/gfq398
22. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D et al. Changes in diabetes-related complications in the United States, 1990-2010. The New England journal of medicine. 2014;370(16):1514-23. doi: 10.1056/NEJMoa1310799 PMID: 24738668
23. Catalano C, Marshall SM. Epidemiology of end-stage renal disease in patients with diabetes mellitus: from the dark ages to the middle ages. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 1992;7(3):181-90.
24. Ritz E, Rychlik I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34(5):795-808. doi: 10.1016/S0272-6386 (99) 70035-1 PMID: 10561134
25. Lopes AA. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethn Dis. 2009;19(1 Suppl 1):S1-47-51.
26. Hill CJ, Fogarty DG. Changing trends in end-stage renal disease due to diabetes in the United kingdom. J Ren Care. 2012;38 Suppl 1:12-22. doi: 10.1111/j.1755-6686.2012.00273.x PMID: 22348360
27. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097 PMID: 19621072
28. Cochrane Consumers and Communication Review Group. Guide for Review Authors on assessing study quality. 2011. http://cccrg.cochrane.org/sites/cccrg.cochrane.org/files/uploads/StudyQualityGuide-May2011.pdf. Accessed 22 Jan 2015.
29. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Annals of internal medicine. 1989;111(10):788-96. PMID: 2817626
30. Uchigata Y, Asao K, Matsushima M, Sato A, Yokoyama H, Otani T et al. Impact on mortality and incidence of end-stage renal disease of education and treatment at a diabetes center among patients with type 1 diabetes: comparison of two subgroups in the Japanese DERI cohort. J Diabetes Complications. 2004;18(3):155-9. doi: 10.1016/j.jdiacomp. 2003.10.002 PMID: 15145326
31. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes care. 2011;34(4):861-6. doi: 10.2337/dc10-1722 PMID: 21307382
32. Lecaire TJ, Klein BE, Howard KP, Lee KE, Klein R. Risk for end-stage renal disease over 25 years in the population-based WESDR cohort. Diabetes care. 2014;37(2):381-8. doi: 10.2337/dc13-1287 PMID: 24026564
33. Bruno G, Biggeri A, Merletti F, Bargero G, Ferrero S, Pagano G et al. Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study. Diabetes care. 2003;26(8):2353-8. PMID: 12882861
34. Nelson RG, Newman JM, Knowler WC, Sievers ML, Kunzelman CL, Pettitt DJ et al. Incidence of endstage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia. 1988;31(10):730-6. PMID: 3240833
35. Muntner P, Coresh J, Powe NR, Klag MJ. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol. 2003;14(6):1568-77. PMID: 12761257
36. Comas J, Arcos E, Castell C, Cases A, Martinez-Castelao A, Donate T et al. Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2013;28(5):1191-8. doi: 10.1093/ndt/gfs507
37. Mollsten A, Svensson M, Waernbaum I, Berhan Y, Schon S, Nystrom L et al. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes. 2010;59(7):1803-8. doi: 10.2337/db09-1744 PMID: 20424230
38. Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. Jama. 2005;294(14):1782-7. doi: 10.1001/jama.294.14.1782 PMID: 16219881
39. Nishimura R, Dorman JS, Bosnyak Z, Tajima N, Becker DJ, Orchard TJ et al. Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry. Am J Kidney Dis. 2003;42(1):117-24. PMID: 12830463
40. Lin WH, Li CY, Wang WM, Yang DC, Kuo TH, Wang MC. Incidence of end stage renal disease among type 1 diabetes: a nationwide cohort study in Taiwan. Medicine (Baltimore). 2014;93(28):e274. doi: 10. 1097/MD.0000000000000274
41. Dyck RF, Jiang Y, Osgood ND. The long-term risks of end stage renal disease and mortality among First Nations and non-First Nations people with youth-onset diabetes. Can J Diabetes. 2014;38(4):237-43. doi: 10.1016/j.jcjd.2014.03.005 PMID: 24986804
42. Matsushima M, Tajima N, LaPorte RE, Orchard TJ, Tull ES, Gower IF et al. Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U. S.-Japan Mortality Study Group. Diabetologia. 1995;38(2):236-43. PMID: 7713320
43. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. The New England journal of medicine. 1989;321(16):1074-9. doi: 10.1056/NEJM198910193211603 PMID: 2797067
44. Pugh JA, Medina RA, Cornell JC, Basu S. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community. Diabetes. 1995;44(12):1375-80. PMID: 7589841
45. Stephens GW, Gillaspy JA, Clyne D, Mejia A, Pollak VE. Racial differences in the incidence of endstage renal disease in types I and II diabetes mellitus. Am J Kidney Dis. 1990;15(6):562-7. PMID: 2368696
46. Burrows NR, Narva AS, Geiss LS, Engelgau MM, Acton KJ. End-stage renal disease due to diabetes among southwestern American Indians, 1990-2001. Diabetes care. 2005;28(5):1041-4. PMID: 15855564
47. Burrows NR, Hora I, Williams DE, Geiss LS. Trends in incidence of end-stage renal disease among persons with diagnosed diabetes-Puerto Rico, 1996-2010. MMWR Morb Mortal Wkly Rep. 2014;63(9):186-9. PMID: 24598594
48. Prevention CfDCa. Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons With Diagnosed Diabetes-United States and Puerto Rico, 1996-2007. MMWR Morb Mortal Wkly Rep. 2010;59(42):1361-90. PMID: 21030940
49. Prevention CfDCa. Incidence of Treatment for End-Stage Renal Disease Attributed to Diabetes Mellitus-United States, 1980-1989 MMWR Morb Mortal Wkly Rep. 1992;41(44) (November 06):834-7.
50. Prevention CfDCa. Incidence of Treatment for End-Stage Renal Disease Attributed to Diabetes Mellitus, by Race/Ethnicity. MMWR Morb Mortal Wkly Rep. 1992;41(44) (November 06):845, 7-8.
51. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney international. 2005;67(5):1684-91. doi: 10.1111/j.1523-1755.2005.00265.x PMID: 15840014
52. Lopes AA, Port FK. Differences in the patterns of age-specific black/white comparisons between endstage renal disease attributed and not attributed to diabetes. Am J Kidney Dis. 1995;25(5):714-21. PMID: 7747725
53. Newman JM, Marfin AA, Eggers PW, Helgerson SD. End state renal disease among Native Americans, 1983-86. Am J Public Health. 1990;80(3):318-9. PMID: 2305914
54. Burden AC, McNally PG, Feehally J, Walls J. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabetic medicine: a journal of the British Diabetic Association. 1992;9(7):641-5.
55. Lorenzo V, Boronat M, Saavedra P, Rufino M, Maceira B, Novoa FJ et al. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2010;25(7):2283-8. doi: 10.1093/ndt/gfp761
56. Lee ET, Lee VS, Lu M, Lee JS, Russell D, Yeh J. Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study. Diabetes. 1994;43(4):572-9. PMID: 8138063
57. Owen WF Jr. Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis. Blood Purif. 1996;14(4):278-85. PMID: 8873953
58. Smith SR, Svetkey LP, Dennis VW. Racial differences in the incidence and progression of renal diseases. Kidney international. 1991;40(5):815-22. PMID: 1762285
59. Incidence and Predictors of End Stage Renal Disease among Low-Income Whites and Blacks [database on the Internet]. National Cancer Institute USA. 2012. Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048407. Accessed: 16 March 2015
60. Bergrem H, Leivestad T. Diabetic nephropathy and end-stage renal failure: the Norwegian story. Advances in renal replacement therapy. 2001;8(1):4-12. PMID: 11172323
61. Assogba FG, Couchoud C, Hannedouche T, Villar E, Frimat L, Fagot-Campagna A et al. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011. Diabetologia. 2014;57(4):718-28. doi: 10.1007/s00125-014-3160-9 PMID: 24496924
62. Villar E, McDonald SP, Couchoud C. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U. S. continues to decline: response to Burrows, Li, and Geiss. Diabetes care. 2010;33(5):e69; author reply e70. doi: 10.2337/dc10-0074 PMID: 20427678
63. Villar E, Chang SH, McDonald SP. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005). Diabetes care. 2007;30(12):3070-6. doi: 10.2337/dc07-0895 PMID: 17848610
64. Stewart JH, McCredie MR, Williams SM, Jager KJ, Trpeski L, McDonald SP et al. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrology. 2007;12(5):520-7. doi: 10. 1111/j.1440-1797.2007.00830.x PMID: 17803478
65. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic medicine: a journal of the British Diabetic Association. 1998;15(7):539-53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0. CO;2-S